Atrial Fibrillation History Feature vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Pathway Labs

AI Verdict

Tool A, Apple's AFib History Feature, focuses on providing retrospective estimates of AFib burden and insights into lifestyle factors for users already diagnosed with AFib, utilizing data from an Apple Watch. In contrast, Tool B, EchoNext, is an AI tool that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, for diagnostic support. While both are cardiology AI tools, Tool A is a personal monitoring tool for managing a known condition, whereas Tool B is a diagnostic aid for healthcare professionals to screen for undiagnosed structural heart issues.

Choose Atrial Fibrillation History Feature if…

Choose the Atrial Fibrillation History Feature if you are a patient already diagnosed with AFib and want to retrospectively track your AFib burden and understand how lifestyle factors like sleep, activity, and alcohol consumption may influence your condition. This tool is also beneficial for sharing a summary of your AFib history with your healthcare provider to inform treatment discussions.

View Atrial Fibrillation History Feature →

Choose EchoNext if…

Choose EchoNext if you are a clinician seeking an FDA-cleared AI tool to analyze standard ECGs for the detection of hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension. This tool is ideal for identifying patients who may require further diagnostic imaging, such as an echocardiogram, especially in settings where access to such imaging is limited.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Atrial Fibrillation History Feature EchoNext
Pricing Included with apple watch Starts at $600/month
Deployment Apple Watch (Series 4 or later) and iPhone (Health app) Available through the OpenEvidence clinical decision support platform.
BAA Available No AI-estimated Yes AI-estimated
FDA Status Yes AI-estimated Yes AI-estimated
HIPAA No AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Atrial Fibrillation History Feature

Apple's AFib History Feature is integrated directly into the Apple Watch and iPhone Health app, leveraging a device many users already own and are familiar with. This provides a seamless and accessible user experience for tracking AFib burden and lifestyle factors. EchoNext, while integrated into the OpenEvidence platform, is a clinical decision support tool for healthcare providers, implying a more complex workflow within a clinical setting.

Clinical Value

EchoNext

EchoNext is an FDA-cleared AI tool that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, with studies showing it outperforms cardiologists in detection accuracy. The Apple AFib History Feature provides retrospective estimates of AFib burden for diagnosed users and insights into lifestyle factors, which is valuable for self-management and physician review, but it is not intended for real-time diagnosis or continuous monitoring.

Pricing & Value

Atrial Fibrillation History Feature

Apple's AFib History Feature is included with the purchase of a compatible Apple Watch, making it accessible to a broad consumer base without additional subscription costs. EchoNext, while offering significant clinical value, has a tiered pricing model starting at $600/month, which, despite potential annual discounts and add-ons, represents a substantial ongoing cost for healthcare providers.

Enterprise Readiness

EchoNext

EchoNext is designed for broad access from major hospitals to community practices and is deployed through the OpenEvidence clinical decision support platform, which is used by a significant portion of US clinicians. It also offers a Business Associate Agreement (BAA) and is HIPAA compliant, crucial for enterprise healthcare environments. Apple's AFib History, while FDA-cleared and used by cardiologists in workflows, lacks a BAA and explicit HIPAA compliance, which are typically prerequisites for enterprise-level healthcare integrations.

Innovation

Tie

Both tools demonstrate significant innovation in their respective domains. Apple's AFib History Feature innovates by making retrospective AFib burden estimation and lifestyle correlation accessible to consumers via a wearable device. EchoNext is groundbreaking as the first FDA-cleared AI tool to detect multiple types of hidden structural heart disease from a standard ECG, outperforming human cardiologists.

Support & Docs

Atrial Fibrillation History Feature

Apple provides extensive user-facing documentation and support for its products, including detailed instructions for use for the AFib History Feature, readily available through its website and the Health app. While EchoNext is a sophisticated clinical tool, specific details regarding its ongoing support and documentation for healthcare providers are not as transparently available in the provided information, though it is deployed through a clinical decision support platform which likely offers its own support structure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Atrial Fibrillation History Feature EchoNext
Name Atrial Fibrillation History Feature EchoNext
Company Apple Pathway Labs
Description Apple's AFib History Feature on Apple Watch provides diagnosed users with retrospective estimates of AFib burden and insights into how lifestyle factors may influence their condition, with data exportable for physician review. EchoNext is an FDA-cleared AI tool from Pathway Labs that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.
Primary Function Retrospective AFib burden estimation and lifestyle factor insights AI-powered ECG analysis for detection of hidden structural heart disease
Target User/Application Diagnosed AFib patients for personal tracking and physician review Healthcare providers for diagnostic support in detecting structural heart disease

Videos

Demos, reviews, and walkthroughs featuring Atrial Fibrillation History Feature and EchoNext.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Apple AFib History Feature is designed for patient use with data exportable as a PDF for physician review, and 76% of cardiac practices have integrated Apple HealthKit data directly into their EHR systems. EchoNext integrates with the OpenEvidence clinical decision support platform, allowing clinicians to submit ECG readings and receive structural heart disease predictions within a platform many physicians already use.
The Apple AFib History Feature provides weekly AFib burden estimates with an average difference of 0.67% compared to a reference ECG patch, and 92.9% of subjects had differences within u00b15%. EchoNext achieved an AUROC of 85% in internal tests and 78-80% in external validation for detecting structural heart disease, and in a study, it demonstrated 77% accuracy compared to cardiologists' 64% at baseline.
The Apple AFib History Feature is primarily suited for cardiology, family medicine, and internal medicine, focusing on retrospective AFib burden estimation for diagnosed patients. EchoNext is relevant for cardiology, family medicine, hospital medicine, and internal medicine, as it analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.
The Apple AFib History Feature is patient-centric, so the physician's learning curve involves understanding the PDF export and integrating patient-provided data. EchoNext, integrated with OpenEvidence, aims to streamline the workflow by providing AI-powered analysis of standard ECGs, suggesting a relatively low learning curve for physicians already familiar with ECG interpretation and the OpenEvidence platform.
The Apple AFib History Feature relies on individual patient adoption of Apple Watches, with data aggregated through HealthKit, which can be integrated into EHR systems across multiple practices. EchoNext, deployed through the OpenEvidence platform, is designed for broad access from major hospitals to community practices, with Pathway Labs focused on national scale deployment across health systems.

Backers

Who funded each tool's parent company.

Atrial Fibrillation History Feature

AI Tool Finder
AI-powered search. Results may not be comprehensive.